Alan Herbert, InsideOutBio, discusses the significant advancements in RNA therapeutics, highlighting their role in supporting ...
Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation for oncology and neurological disorders, ...
Cancers driven by hiccups in RNA processing can’t hide from our immune system, according to new work published today in Cell. A cross-institutional team Fred Hutch Cancer Center and Memorial Sloan ...
The IDR in TAF2 steers the protein away from active gene promoters, where it participates in transcription initiation, to nuclear speckles — liquid-like compartments that concentrate factors for RNA ...
To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where they read the genetic instructions from messenger RNA, mRNA, and deliver the ...
The Cool Down on MSN
Scientists discover concerning new threat to human brain health: 'Expected to be a key turning point'
The researchers treated mouse serum with microplastics to form the microplastics that absorbed proteins, according to a ...
miRecule, a biotechnology company focusing on RNA therapies, and GBI Biomanufacturing, a CDMO, partnered to advance the development and clinical supply of miRecule’s Antibody-RNA Conjugate (ARC) based ...
For a Brandeis undergraduate, the Brandeis Core Science requirement has inevitably brought you to a classroom where the words ...
When doctors prescribe oxybutynin, it's usually for an unglamorous problem: bladder incontinence. But researchers have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback